Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neisseria meningitidis, Serogroup C | 3 | 2019 | 46 | 1.10 | Why? |
| Meningitis, Meningococcal | 3 | 2018 | 114 | 0.99 | Why? |
| Boutonneuse Fever | 1 | 2018 | 21 | 0.77 | Why? |
| Hospital Records | 1 | 2018 | 55 | 0.76 | Why? |
| Meningococcal Vaccines | 2 | 2018 | 225 | 0.73 | Why? |
| Tetanus | 1 | 2018 | 61 | 0.71 | Why? |
| Diphtheria | 1 | 2018 | 74 | 0.70 | Why? |
| Immunization Programs | 3 | 2019 | 2006 | 0.61 | Why? |
| Italy | 47 | 2021 | 38444 | 0.53 | Why? |
| Emigrants and Immigrants | 2 | 2019 | 888 | 0.49 | Why? |
| Vaccination Coverage | 2 | 2019 | 1249 | 0.48 | Why? |
| Immunization Schedule | 1 | 2019 | 1305 | 0.45 | Why? |
| Meningococcal Infections | 3 | 2019 | 216 | 0.44 | Why? |
| Communicable Diseases | 3 | 2020 | 2148 | 0.38 | Why? |
| Echinococcosis | 2 | 2019 | 40 | 0.38 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.37 | Why? |
| Haemophilus Infections | 2 | 2018 | 69 | 0.36 | Why? |
| Vaccines | 4 | 2021 | 3692 | 0.35 | Why? |
| Chikungunya virus | 2 | 2019 | 339 | 0.29 | Why? |
| Population Surveillance | 8 | 2020 | 4967 | 0.29 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.28 | Why? |
| Chikungunya Fever | 2 | 2019 | 345 | 0.27 | Why? |
| Disease Outbreaks | 8 | 2019 | 27595 | 0.24 | Why? |
| Mortality | 6 | 2020 | 7132 | 0.23 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.23 | Why? |
| Schools, Nursery | 1 | 2020 | 26 | 0.22 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.21 | Why? |
| Trichinellosis | 1 | 2019 | 6 | 0.21 | Why? |
| Heterosexuality | 2 | 2018 | 148 | 0.20 | Why? |
| Meningitis, Haemophilus | 1 | 2018 | 12 | 0.20 | Why? |
| Infant | 12 | 2020 | 30274 | 0.19 | Why? |
| Meningitis, Pneumococcal | 1 | 2018 | 35 | 0.19 | Why? |
| Meat Products | 1 | 2018 | 39 | 0.19 | Why? |
| Listeriosis | 1 | 2018 | 36 | 0.18 | Why? |
| Child, Adopted | 1 | 2018 | 15 | 0.18 | Why? |
| Spatio-Temporal Analysis | 3 | 2020 | 1182 | 0.18 | Why? |
| Salmonella enterica | 1 | 2018 | 39 | 0.18 | Why? |
| Listeria monocytogenes | 1 | 2018 | 68 | 0.18 | Why? |
| Abdomen | 2 | 2019 | 424 | 0.18 | Why? |
| Child, Preschool | 12 | 2020 | 36283 | 0.18 | Why? |
| Infant, Newborn | 8 | 2020 | 23105 | 0.17 | Why? |
| Bisexuality | 1 | 2018 | 119 | 0.17 | Why? |
| Foodborne Diseases | 1 | 2018 | 89 | 0.17 | Why? |
| Tetanus Toxoid | 1 | 2018 | 136 | 0.17 | Why? |
| Salmonella Infections | 1 | 2018 | 82 | 0.17 | Why? |
| Food Contamination | 1 | 2018 | 142 | 0.17 | Why? |
| West Nile virus | 1 | 2018 | 206 | 0.16 | Why? |
| History, 21st Century | 3 | 2019 | 1849 | 0.16 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.16 | Why? |
| Microbiology | 1 | 2018 | 134 | 0.16 | Why? |
| School Teachers | 1 | 2020 | 345 | 0.16 | Why? |
| Communicable Disease Control | 5 | 2021 | 29620 | 0.16 | Why? |
| West Nile Fever | 1 | 2018 | 166 | 0.16 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2019 | 214 | 0.15 | Why? |
| Rural Population | 2 | 2019 | 2408 | 0.15 | Why? |
| Incidence | 10 | 2021 | 25622 | 0.15 | Why? |
| Schools | 3 | 2021 | 4187 | 0.15 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 282 | 0.15 | Why? |
| Morbidity | 2 | 2021 | 1426 | 0.15 | Why? |
| Young Adult | 15 | 2020 | 93724 | 0.14 | Why? |
| Homosexuality, Male | 3 | 2019 | 1158 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.14 | Why? |
| Zoonoses | 2 | 2019 | 3034 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2018 | 306 | 0.14 | Why? |
| Adolescent | 16 | 2020 | 86841 | 0.14 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.13 | Why? |
| Male | 35 | 2021 | 367725 | 0.13 | Why? |
| Child | 14 | 2020 | 70012 | 0.13 | Why? |
| Aedes | 1 | 2017 | 380 | 0.13 | Why? |
| Female | 35 | 2021 | 380317 | 0.13 | Why? |
| Women's Health | 1 | 2019 | 444 | 0.13 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.13 | Why? |
| Polymorphism, Genetic | 1 | 2021 | 1074 | 0.13 | Why? |
| Humans | 57 | 2021 | 930598 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.12 | Why? |
| Patient Discharge | 2 | 2019 | 5696 | 0.12 | Why? |
| Klebsiella pneumoniae | 1 | 2019 | 658 | 0.12 | Why? |
| Adult | 24 | 2021 | 244371 | 0.12 | Why? |
| beta-Lactamases | 1 | 2019 | 759 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2021 | 1168 | 0.12 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.12 | Why? |
| General Practitioners | 1 | 2019 | 568 | 0.12 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.11 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.11 | Why? |
| Measles | 1 | 2019 | 608 | 0.11 | Why? |
| Sexual and Gender Minorities | 2 | 2019 | 1019 | 0.11 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.11 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.11 | Why? |
| Escherichia coli | 1 | 2019 | 1547 | 0.11 | Why? |
| Refugees | 1 | 2021 | 809 | 0.11 | Why? |
| Carrier State | 2 | 2019 | 2100 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.10 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.10 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.10 | Why? |
| Patient Acceptance of Health Care | 2 | 2019 | 5002 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| HIV Infections | 4 | 2020 | 11620 | 0.09 | Why? |
| Sexually Transmitted Diseases | 1 | 2017 | 694 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.09 | Why? |
| Nerve Growth Factor | 1 | 2008 | 38 | 0.09 | Why? |
| Transients and Migrants | 1 | 2021 | 1468 | 0.09 | Why? |
| Nerve Degeneration | 1 | 2008 | 73 | 0.09 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.09 | Why? |
| Thyroid Neoplasms | 1 | 2013 | 422 | 0.09 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.08 | Why? |
| Socioeconomic Factors | 3 | 2021 | 8495 | 0.08 | Why? |
| Mass Screening | 2 | 2018 | 8005 | 0.08 | Why? |
| Dementia | 1 | 2020 | 1861 | 0.08 | Why? |
| Prevalence | 8 | 2020 | 25773 | 0.08 | Why? |
| Aged, 80 and over | 8 | 2020 | 88759 | 0.08 | Why? |
| Serogroup | 2 | 2019 | 510 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.07 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.07 | Why? |
| Aged | 14 | 2021 | 215776 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.07 | Why? |
| Intensive Care Units, Neonatal | 1 | 2010 | 749 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Blood Donors | 1 | 2018 | 2956 | 0.07 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2020 | 3222 | 0.07 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Brain Injuries | 1 | 2008 | 374 | 0.06 | Why? |
| CD4 Lymphocyte Count | 2 | 2018 | 1517 | 0.06 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.06 | Why? |
| Students | 1 | 2020 | 5255 | 0.06 | Why? |
| Vulnerable Populations | 1 | 2017 | 3099 | 0.06 | Why? |
| Disease Notification | 2 | 2018 | 639 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.05 | Why? |
| Trichinella | 1 | 2019 | 2 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Europe, Eastern | 1 | 2019 | 88 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.05 | Why? |
| Clavulanic Acid | 1 | 2018 | 20 | 0.05 | Why? |
| Europe | 3 | 2021 | 12702 | 0.05 | Why? |
| Registries | 1 | 2019 | 12327 | 0.05 | Why? |
| Phylogeny | 4 | 2018 | 13341 | 0.05 | Why? |
| Polymerase Chain Reaction | 3 | 2019 | 6740 | 0.05 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.05 | Why? |
| Haemophilus Vaccines | 1 | 2018 | 76 | 0.05 | Why? |
| Serotyping | 1 | 2018 | 154 | 0.05 | Why? |
| Bulgaria | 1 | 2018 | 117 | 0.05 | Why? |
| Cities | 2 | 2020 | 4937 | 0.04 | Why? |
| Serbia | 1 | 2018 | 227 | 0.04 | Why? |
| Amoxicillin | 1 | 2018 | 98 | 0.04 | Why? |
| Haemophilus influenzae | 1 | 2018 | 196 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2019 | 264 | 0.04 | Why? |
| Turkey | 2 | 2019 | 3937 | 0.04 | Why? |
| Food Handling | 1 | 2018 | 103 | 0.04 | Why? |
| Azathioprine | 1 | 2018 | 161 | 0.04 | Why? |
| Mumps | 1 | 2019 | 110 | 0.04 | Why? |
| Hepatitis Antibodies | 1 | 2018 | 100 | 0.04 | Why? |
| Rubella | 1 | 2019 | 127 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| Measles virus | 1 | 2019 | 194 | 0.04 | Why? |
| Urban Health | 1 | 2020 | 382 | 0.04 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.04 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.04 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.04 | Why? |
| Mosquito Vectors | 1 | 2019 | 351 | 0.04 | Why? |
| Cause of Death | 2 | 2020 | 4823 | 0.04 | Why? |
| Risk | 2 | 2020 | 5288 | 0.04 | Why? |
| Research Report | 1 | 2020 | 376 | 0.04 | Why? |
| Gene Frequency | 1 | 2021 | 1210 | 0.04 | Why? |
| Romania | 1 | 2018 | 590 | 0.04 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.04 | Why? |
| Metabolic Diseases | 1 | 2021 | 505 | 0.04 | Why? |
| Escherichia coli Infections | 1 | 2019 | 348 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Animals | 6 | 2019 | 78931 | 0.03 | Why? |
| Greece | 1 | 2021 | 2091 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Klebsiella Infections | 1 | 2019 | 466 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Geography | 1 | 2019 | 1801 | 0.03 | Why? |
| Sepsis | 1 | 2010 | 3517 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.03 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.03 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.03 | Why? |
| Hospitals, University | 2 | 2018 | 4173 | 0.03 | Why? |
| Ultrasonography | 2 | 2019 | 4409 | 0.03 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.03 | Why? |
| Emigration and Immigration | 1 | 2018 | 501 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2021 | 1529 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Counseling | 1 | 2017 | 747 | 0.03 | Why? |
| Infant, Very Low Birth Weight | 1 | 2010 | 62 | 0.03 | Why? |
| Brain | 1 | 2008 | 5133 | 0.03 | Why? |
| Surveys and Questionnaires | 4 | 2019 | 43792 | 0.03 | Why? |
| Oropharynx | 1 | 2019 | 1581 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.02 | Why? |
| Interleukin-6 | 1 | 2008 | 7522 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.02 | Why? |
| Birth Weight | 1 | 2010 | 250 | 0.02 | Why? |
| Glasgow Outcome Scale | 1 | 2008 | 56 | 0.02 | Why? |
| Cytoprotection | 1 | 2008 | 44 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.02 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Sexual Behavior | 1 | 2017 | 1322 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.02 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Gestational Age | 1 | 2010 | 1488 | 0.02 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.02 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.02 | Why? |
| Healthcare Disparities | 1 | 2021 | 3893 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.01 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Neurons | 1 | 2008 | 864 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.01 | Why? |
| Early Detection of Cancer | 1 | 2013 | 1956 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2018 | 9091 | 0.01 | Why? |
| Encephalitis | 1 | 2008 | 797 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Up-Regulation | 1 | 2008 | 2249 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Proportional Hazards Models | 1 | 2010 | 6543 | 0.01 | Why? |
| Recovery of Function | 1 | 2008 | 2461 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2008 | 9537 | 0.01 | Why? |
| Length of Stay | 1 | 2010 | 11042 | 0.01 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Biomarkers | 1 | 2008 | 23361 | 0.00 | Why? |